Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aelicure Pharma is a research-driven biotechnology company based in Hyderabad, India, focused on the discovery and development of novel small molecule therapeutics. The company primarily targets unmet medical needs in oncology and inflammatory diseases by identifying and modulating specific biological pathways involved in disease progression. Currently in the preclinical stage, Aelicure leverages its internal expertise in medicinal chemistry to build a proprietary pipeline of drug candidates. Their approach emphasizes structure-based drug design to create highly selective and potent molecules. As an emerging player in the Indian biotech sector, Aelicure aims to transition from early-stage research to clinical development through strategic growth and innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aelicure Pharma.